Sustainable Value Creation Model

Discover Our Model


Value Realization

Clinical validation

Global out-licensing deals


Value Realization

Fast-to-market in China

Maximize commercial value


R&D Engine

Competitive advantages in immuno-oncology

Globally competitive pipeline in 3 generations

Our Proven Value Creation Model Is
Enabled by Differentiated Global Capabilities

Deep Immunology Expertise

  • Led by principal scientists with decades of research and drug discovery expertise in pharma R&D
  • Extensive research in immune regulatory pathways
  • 200+ publications by in-house experts in high-impact scientific journals
  • 12 novel drug molecules advanced into the clinic since 2016

Global Clinical Development

  • Led by world-renowned oncologists with global clinical and drug development expertise in hematology and solid tumors
  • Excellent track record in developing innovative oncology drugs
  • 300+ medical science publications by in-house experts in high-impact journals
  • 14 trials conducted in China, 8 trials conducted in the US, involving more than 1,000 patients worldwide by I-Mab
Note: Achievements accumulated during their careers.

Maryland – Global HQ

Shanghai – International center for discovery and operations

Other Locations

  • Beijing – Clinical operations and regulatory
  • I-Mab Hangzhou – GMP manufacturing facility
  • San Diego – Translational medicine

Global Partnerships

  • > 15 deals

Commercial Partnerships

  • > 5 deals (including Jumpcan)

Our business is powered by our diverse and experienced global talents

  • 70%

    R&D Personnel

  • 70%

    Female Employees

  • 61%

    Global Experience

  • 60%

    Advanced Degrees

We have a professional management team with proven track record of success